Human adipose-derived stromal/stem cells protect against STZ-induced hyperglycemia: Analysis of hASC-derived paracrine effectors

Stem Cells

Volumn 32, Issue 7, 2014, Pages 1831-1842

  Kono, Tatsuyoshi M ^a   Sims, Emily K ^a   Moss, Dan R ^a   Yamamoto, Wataru ^a   Ahn, Geonyoung ^a   Diamond, Julie ^a   Tong, Xin ^a   Day, Kathleen H ^a   Territo, Paul R ^a   Hanenberg, Helmut ^a   Traktuev, Dmitry O ^a,b,c   March, Keith L ^a,b,c   Evans Molina, Carmella ^a,b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adipose stem cells; Caspase; Cellular proliferation; Diabetes; Pancreas; Tissue regeneration

Indexed keywords

CASPASE 3; GAMMA INTERFERON; GLUCOSE; INTERLEUKIN 1BETA; RECOMBINANT PROTEIN; STREPTOZOCIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE; TIMP1 PROTEIN, HUMAN;

ADIPOSE DERIVED STEM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL FUNCTION; CELL MASS; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CELLULAR PARAMETERS; CELLULAR STRESS RESPONSE; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; EX VIVO STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NOD SCID MOUSE; NONHUMAN; PANCREAS; PANCREAS ISLET BETA CELL; PARACRINE SIGNALING; PROTEIN CLEAVAGE; SIGNAL TRANSDUCTION; ADULT; ADULT STEM CELL; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL SIZE; CHEMICALLY INDUCED; CYTOLOGY; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE INTOLERANCE; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY; SCID MOUSE; SECRETION (PROCESS); SUBCUTANEOUS FAT; TRANSPLANTATION;

ADULT; ADULT STEM CELLS; ANIMALS; CELL SIZE; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERGLYCEMIA; INSULIN-SECRETING CELLS; MALE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; PARACRINE COMMUNICATION; STREPTOZOCIN; SUBCUTANEOUS FAT; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84901013574     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1676     Document Type: Article

References (49)

1. Tao B, Pietropaolo M, Atkinson M, et al. Estimating the cost of type 1 diabetes in the U.S.: A propensity score matching method. PLoS One 2010; 5: e11501.
2. Control CFD,. National Health Interview Survey. Available at www.cdc.gov. Accessed January 1, 2013.
3. Imperatore G, Boyle JP, Thompson TJ, et al. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: Dynamic modeling of incidence, mortality, and population growth. Diabetes Care 2012; 35: 2515-2520.
4. Patterson CC, Dahlquist GG, Gyurus E, et al. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: A multicentre prospective registration study. Lancet 2009; 373: 2027-2033.
5. Stanescu DE, Lord K, Lipman TH,. The epidemiology of type 1 diabetes in children. Endocrinol Metab Clin North Am 2012; 41: 679-694.
6. Wajchenberg BL, Feitosa AC, Rassi N, et al. Glycemia and cardiovascular disease in type 1 diabetes mellitus. Endocr Pract 2008; 14: 912-923.
7. Trence DL, Hirsch IB,. Motherhood, apple pie, hemoglobin A(1C), and the DCCT. Endocr Pract 2012; 18: 78-84.
8. Barton FB, Rickels MR, Alejandro R, et al. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 2012; 35: 1436-1445.
9. Gruessner AC, Sutherland DE, Gruessner RW,. Long-term outcome after pancreas transplantation. Curr Opin Organ Transplant 2012; 17: 100-105.
10. Xie R, Everett LJ, Lim HW, et al. Dynamic chromatin remodeling mediated by polycomb proteins orchestrates pancreatic differentiation of human embryonic stem cells. Cell Stem Cell 2013; 12: 224-237.
11. Lee RH, Seo MJ, Reger RL, et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci USA 2006; 103: 17438-17443.
12. Ezquer F, Ezquer M, Contador D, et al. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment. Stem Cells 2012; 30: 1664-1674.
13. Bell GI, Putman DM, Hughes-Large JM, et al. Intrapancreatic delivery of human umbilical cord blood aldehyde dehydrogenase-producing cells promotes islet regeneration. Diabetologia 2012; 55: 1755-1760.
14. Schweitzer KS, Johnstone BH, Garrison J, et al. Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med 2011; 183: 215-225.
15. Cai L, Johnstone BH, Cook TG, et al. Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. Stem Cells 2007; 25: 3234-3243.
16. Wei X, Zhao L, Zhong J, et al. Adipose stromal cells-secreted neuroprotective media against neuronal apoptosis. Neurosci Lett 2009; 462: 76-79.
17. Hadad I, Johnstone BH, Brabham JG, et al. Development of a porcine delayed wound-healing model and its use in testing a novel cell-based therapy. Int J Radiat Oncol Biol Phys 2010; 78: 888-896.
18. Hong SJ, Traktuev DO, March KL,. Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair. Curr Opin Organ Transplant 2010; 15: 86-91.
19. Fumimoto Y, Matsuyama A, Komoda H, et al. Creation of a rich subcutaneous vascular network with implanted adipose tissue-derived stromal cells and adipose tissue enhances subcutaneous grafting of islets in diabetic mice. Tissue Eng Part C Methods 2009; 15: 437-444.
20. Bassi EJ, Moraes-Vieira PM, Moreira-Sa CS, et al. Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes. Diabetes 2012; 61: 2534-2545.
21. Cai S, Wang H, Bailey B, et al. Humanized bone marrow mouse model as a preclinical tool to assess therapy-mediated hematotoxicity. Clin Cancer Res 2011; 17: 2195-2206.
22. Animals CFTUOTGFTCAUOL. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academies Press, 2011.
23. Evans-Molina C, Robbins RD, Kono T, et al. Peroxisome proliferator-activated receptor gamma activation restores islet function in diabetic mice through reduction of endoplasmic reticulum stress and maintenance of euchromatin structure. Mol Cell Biol 2009; 29: 2053-2067.
24. Stull ND, Breite A, McCarthy R, et al. Mouse islet of Langerhans isolation using a combination of purified collagenase and neutral protease. J Vis Exp 2012. pii: 4137.
25. Kono T, Ahn G, Moss DR, et al. PPAR-gamma activation restores pancreatic islet SERCA2 levels and prevents beta-cell dysfunction under conditions of hyperglycemic and cytokine stress. Mol Endocrinol 2012; 26: 257-271.
26. Traktuev DO, Prater DN, Merfeld-Clauss S, et al. Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells. Circ Res 2009; 104: 1410-1420.
27. Nitsche A, Becker M, Junghahn I, et al. Quantification of human cells in NOD/SCID mice by duplex real-time polymerase-chain reaction. Haematologica 2001; 86: 693-699.
28. Sin CF, Leung CK,. Image segmentation by edge pixel classification with maximum entropy. From the International Symposium on Intelligent Multimedia, Video, and Speech Processing. Hong Kong: IEEE Conference Publications, 2001.
29. Maier B, Ogihara T, Trace AP, et al. The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice. J Clin Invest 2010; 120: 2156-2170.
30. Sims EK, Hatanaka M, Morris DL, et al. Divergent compensatory responses to high-fat diet between C57BL6/J and C57BLKS/J inbred mouse strains. Am J Physiol Endocrinol Metab 2013; 305: E1495-1511.
31. Ogihara T, Chuang JC, Vestermark GL, et al. Liver X receptor agonists augment human islet function through activation of anaplerotic pathways and glycerolipid/free fatty acid cycling. J Biol Chem 2010; 285: 5392-5404.
32. Levetan CS, Pierce SM,. Distinctions between the islets of mice and men: Implications for new therapies for type 1 and 2 diabetes. Endocr Pract 2012: 1-36.
33. Wei Y, Mizzen CA, Cook RG, et al. Phosphorylation of histone H3 at serine 10 is correlated with chromosome condensation during mitosis and meiosis in tetrahymena. Proc Natl Acad Sci USA 1998; 95: 7480-7484.
34. Lee MJ, Kim J, Kim MY, et al. Proteomic analysis of tumor necrosis factor-alpha-induced secretome of human adipose tissue-derived mesenchymal stem cells. J Proteome Res 2010; 9: 1754-1762.
35. Jiang H, Zhu H, Chen X, et al. TIMP-1 transgenic mice recover from diabetes induced by multiple low-dose streptozotocin. Diabetes 2007; 56: 49-56.
36. Han X, Sun Y, Scott S, et al. Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and beta-cells. Diabetes 2001; 50: 1047-1055.
37. Stetler-Stevenson WG,. Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci Signal 2008; 1: re6.
38. Kang S, Park EJ, Joe Y, et al. Systemic delivery of TNF-related apoptosis-inducing ligand (TRAIL) elevates levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and prevents type 1 diabetes in nonobese diabetic mice. Endocrinology 2010; 151: 5638-5646.
39. Papaccio G, Chieffi-Baccari G,. Alterations of islet microvasculature in mice treated with low-dose streptozocin. Histochemistry 1992; 97: 371-374.
40. Watada H,. Role of VEGF-A in pancreatic beta cells. Endocr J 2010; 57: 185-191.
41. Zhang S, Dai H, Wan N, et al. Promoting long-term survival of insulin-producing cell grafts that differentiate from adipose tissue-derived stem cells to cure type 1 diabetes. PLoS One 2011; 6: e29706.
42. Chandra V, Swetha G, Muthyala S, et al. Islet-like cell aggregates generated from human adipose tissue derived stem cells ameliorate experimental diabetes in mice. PLoS One 2011; 6: e20615.
43. Dave SD, Trivedi HL, Chooramani SG, et al. Management of type 1 diabetes mellitus using in vitro autologous adipose tissue trans-differentiated insulin-making cells. BMJ Case Rep 2013; 2013.
44. Blondel O, Bailbe D, Portha B,. In vivo insulin resistance in streptozotocin-diabetic rats-Evidence for reversal following oral vanadate treatment. Diabetologia 1989; 32: 185-190.
45. Safwani WK, Makpol S, Sathapan S, et al. The impact of long-term in vitro expansion on the senescence-associated markers of human adipose-derived stem cells. Appl Biochem Biotechnol 2012; 166: 2101-2113.
46. Wan Safwani WK, Makpol S, Sathapan S, et al. The changes of stemness biomarkers expression in human adipose-derived stem cells during long-term manipulation. Biotechnol Appl Biochem 2011; 58: 261-270.
47. Cramer C, Freisinger E, Jones RK, et al. Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells. Stem Cells Dev 2010; 19: 1875-1884.
48. MacIsaac ZM, Shang H, Agrawal H, et al. Long-term in-vivo tumorigenic assessment of human culture-expanded adipose stromal/stem cells. Exp Cell Res 2012; 318: 416-423.
49. Levine AD, Wolf LE,. The roles and responsibilities of physicians in patients' decisions about unproven stem cell therapies. J Law Med Ethics 2012; 40: 122-134.